Webinar: Leveraging AI for Intelligent Adverse Event and Product Complaint Intake
Join peers from global pharma to explore how ReporterX is redefining safety and quality complaints intake.
Webinar: The Rise of Intelligence Agents
AI Intelligence agents that interpret regulatory change and assess real-time impact.
The DIA 2020 Annual Meeting Is Now Virtual. ArisGlobal will be front and center with presentations covering both Safety and Clinical perspectives in Life Sciences process management.
Regulatory affairs departments are accustomed – and even open -- ...
Advanced computing methods can be used for safety monitoring and early detection of potential signals of vaccine-related adverse events. These methods work by mining open-access active-moiety databases and vast scientific literature with clinical case studies.
On November 28, 2017, ArisGlobal held a webinar with DIA, “How Automation Can Deliver the Holy Grail in Safety: Achieve Productivity, Compliance and Quality”. In this webinar, we posed a few questions to the audience, and came up with some interesting information. We took this and spent some thinking about what this means to our clients in the PV ecosystem.
Rising Expectations from Regulatory Affairs Executives As we all know ...
What will the next generation of reporting and analytics in ...
Learn why Breakthrough is more than just an event but a summit for thought leaders in health and life sciences to discuss today and the future.
The Evolving Role of CTMS in Risk Management takes a broad look at the challenges facing clinical trial management, how the clinical domain is changing, and how the industry can better respond.
In today’s fast paced ‘all or nothing’ innovative solution-focused industry, ...
This is the second in a three-part blog series on National Pharmacovigilance systems and the role of technology in bridging the gaps in pharmacovigilance of regulatory authorities around the world.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved